← Leaderboards
Christopher R Cox
Cobio Diagnostics Inc.
$2,076,284
Attributed
$2,076,284
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $939.6K · FY2020–23$1M$750K$500K$250K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$2,076,284 · 2
By mechanism
R44$1,825,667 · 1
R43$250,617 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Hour”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$44,740,553
- Scott Fry$21,470,000
- Wally Narajowski$21,300,000
- Ashlee Fitch · Steelworker Charitable/Educational Org$19,640,715
- Bradley George Phillips · Emory University$13,241,414
- Kelly A Nee · Boston University Medical Campus$11,664,523
Research focus
HourIncidenceEscherichia ColiGenotypeImmunoassayDiagnosticCostEnzyme-Linked Immunosorbent AssayAntibiotic ResistanceConsumptionAntibioticsDiagnosisAntibodiesBeta-Lactam ResistanceBlindAntimicrobialAntimicrobial SusceptibilityEnterococcus FaecalisBacteriaClinical DiagnosticsBacteriophagesColiphagesColoradoInfection
Grant awards (3)
Rapid phage-amplified immunoassay for phenotypic UTI diagnosis and antimicrobial susceptibility testing$886,085
R44 · FY2023 · DK · contact PI
Rapid phage-amplified immunoassay for phenotypic UTI diagnosis and antimicrobial susceptibility testing$939,582
R44 · FY2022 · DK · contact PI
Rapid phage-amplified immunoassay for phenotypic UTI diagnosis and antimicrobial susceptibility testing$250,617
R43 · FY2020 · DK · contact PI